Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy PelvExCollaborative

被引：59

作者：

Kelly, M. E. ^{[1
]}

Ryan, E. J. ^{[1
]}

Aalbers, A. G. J. ^{[1
]}

Abdul, Aziz N. ^{[1
]}

Abraham-Nordling, M. ^{[1
]}

Alberda, W. ^{[1
]}

Antoniou, A. ^{[1
]}

Austin, K. K. ^{[1
]}

Baker, R. ^{[1
]}

Bali, M. ^{[1
]}

Baseckas, G. ^{[1
]}

Bednarski, B. K. ^{[1
]}

Beets, G. L. ^{[1
]}

Berg, P. L. ^{[1
]}

Beynon, J. ^{[1
]}

Biondo, S. ^{[1
]}

Bordeianou, L. ^{[1
]}

Bremers, A. B. ^{[1
]}

Brunner, M. ^{[1
]}

Buchwald, P. ^{[1
]}

Burger, J. W. A. ^{[1
]}

Burling, D. ^{[1
]}

Campain, N. ^{[1
]}

Chan, K. K. L. ^{[1
]}

Chang, G. J. ^{[1
]}

Chew, M. H. ^{[1
]}

Chong, C. P. ^{[1
]}

Christensen, H. K. ^{[1
]}

Codd, M. ^{[1
]}

Colquhoun, A. J. ^{[1
]}

Corr, A. ^{[1
]}

Coscia, M. ^{[1
]}

Coyne, P. E. ^{[1
]}

Creavin, B. ^{[1
]}

Damjanovic, L. ^{[1
]}

Daniels, I. R. ^{[1
]}

Davies, M. ^{[1
]}

Davies, R. J. ^{[1
]}

de wilt, J. H. W. ^{[1
]}

Denost, Q. ^{[1
]}

Deutsch, C. ^{[1
]}

Dietz, D. ^{[1
]}

Domingo, S. ^{[1
]}

Dozois, E. J. ^{[1
]}

Duff, M. ^{[1
]}

Eglinton, T. ^{[1
]}

Evans, M. D. ^{[1
]}

Fearnhead, N. S. ^{[1
]}

Frizelle, F. A. ^{[1
]}

Garcia-Granero, E. ^{[1
]}

机构：

[1] St Vincents Univ Hosp, Ctr Colorectal Dis, Dublin, Ireland

来源：

ANNALS OF SURGERY | 2019年 / 270卷 / 05期

关键词：

international collaboration; pelvic exenteration; pelvic malignancy; surgical outcomes; survival outcomes; LOCALLY ADVANCED PRIMARY; QUALITY-OF-LIFE; PRIMARY RECTAL-CANCER; RECURRENT; OUTCOMES; SURGERY; EXPERIENCE; RESECTION; EXCISION; RADIOTHERAPY;

D O I：

10.1097/SLA.0000000000003533

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Objective: To determine factors associated with outcomes following pelvic exenteration for advanced nonrectal pelvic malignancy. Background: The PelvEx Collaborative provides large volume data from specialist centers to ascertain factors associated with improved outcomes. Methods: Consecutive patients who underwent pelvic exenteration for nonrectal pelvic malignancy between 2006 and 2017 were identified from 22 tertiary centers. Patient demographics, neoadjuvant therapy, histopathological assessment, length of stay, 30-day major complication/mortality rate were recorded. The primary endpoints were factors associated with survival. The secondary endpoints included the difference in margin rates across the cohorts, impact of neoadjuvant treatment on survival, associated morbidity, and mortality. Results: One thousand two hundred ninety-three patients were identified. 40.4% (n = 523) had gynecological malignancies (endometrial, ovarian, cervical, and vaginal), 35.7% (n = 462) urological (bladder), 18.1% (n = 234) anal, and 5.7% had sarcoma (n = 74). The median age across the cohort was 63 years (range, 23-85). The median 30-day mortality rate was 1.7%, with the highest rates occurring following exenteration for recurrent sarcoma or locally advanced cervical cancer (3.3% each). The median length of hospital stay was 17.5 days. 34.5% of patients experienced a major complication, with highest rate occurring in those having salvage surgery for anal cancer. Multivariable analysis showed R0 resection was the main factor associated with long-term survival. The 3-year overall-survival rate for R0 resection was 48% for endometrial malignancy, 40.6% for ovarian, 49.4% for cervical, 43.8% for vaginal, 59% for bladder, 48.3% for anal, and 48.1% for sarcoma. Conclusion: Pelvic exenteration remains an important treatment in selected patients with advanced or recurrent nonrectal pelvic malignancy. The range in 3-year overall survival following R0 resection (40%-59%) reflects the diversity of tumor types.

引用

页码：899 / 905

页数：7

共 50 条

[1] Pelvic exenteration for advanced pelvic malignancy
Crowe, PJ
Temple, WJ
Lopez, MJ
Ketcham, AS
[J]. SEMINARS IN SURGICAL ONCOLOGY, 1999, 17 (03): : 152 - 160
[2] Pelvic Exenteration for Advanced and Recurrent Malignancy
Evita Zoucas
Sven Frederiksen
Marie-Louise Lydrup
Wiking Månsson
Pelle Gustafson
Per Alberius
[J]. World Journal of Surgery, 2010, 34 : 2177 - 2184
[3] Pelvic Exenteration for Advanced and Recurrent Malignancy
Zoucas, Evita
Frederiksen, Sven
Lydrup, Marie-Louise
Mansson, Wiking
Gustafson, Pelle
Alberius, Per
[J]. WORLD JOURNAL OF SURGERY, 2010, 34 (09) : 2177 - 2184
[4] Cost Analysis of Pelvic Exenteration Surgery for Advanced Pelvic Malignancy
Risbey, Charles W. G.
Brown, Kilian G. M.
Solomon, Michael
Mcbride, Kate
Steffens, Daniel
[J]. ANNALS OF SURGICAL ONCOLOGY, 2024,
[5] EXENTERATION AS PALLIATION FOR PATIENTS WITH ADVANCED PELVIC MALIGNANCY
WOODHOUSE, CRJ
PLAIL, RO
SCHLESINGER, PE
SHEPHERD, JE
HENDRY, WF
BREACH, NM
[J]. BRITISH JOURNAL OF UROLOGY, 1995, 76 (03): : 315 - 320
[6] Pelvic exenteration for advanced malignancy in elderly patients
Radwan, R. W.
Evans, M. D.
Davies, M.
Harris, D. A.
Beynon, J.
[J]. BRITISH JOURNAL OF SURGERY, 2016, 103 (02) : E115 - E119
[7] PELVIC EXENTERATION IN TREATMENT OF ADVANCED MALIGNANCY OF VULVA
THORNTON, WN
FLANAGAN, WC
[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1973, 117 (06) : 774 - 781
[8] OUR EXPERIENCE IN TOTAL PELVIC EXENTERATION FOR FOCALLY ADVANCED PELVIC MALIGNANCY
BILBAO, I
RUIZ, C
CHARCO, R
LAZARO, JL
BALSELLS, J
MURIO, E
GIFRE, E
HIDALGO, E
MARGARIT, C
[J]. BRITISH JOURNAL OF SURGERY, 1995, 82 : 108 - 108
[9] Pelvic exenteration for locally advanced recurrent gynaecological malignancy
Smolarek, S.
Radvan, R.
Evans, M.
Bose, P.
Davies, M.
Harris, D.
Beynon, J.
Lutchman-Singh, K.
[J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 1023 - 1023
[10] Pelvic exenteration for advanced pelvic malignancies
Pawlik, TM
Skibber, JM
Rodriguez-Bigas, MA
[J]. ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (05) : 612 - 623

← 1 2 3 4 5 →